Cargando…
Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Letter]
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707536/ https://www.ncbi.nlm.nih.gov/pubmed/36457761 http://dx.doi.org/10.2147/OTT.S396547 |
_version_ | 1784840722081382400 |
---|---|
author | Panjaitan, Novaria Sari Dewi Lienggonegoro, Lisa Andriani Nikmah, Uly Alfi |
author_facet | Panjaitan, Novaria Sari Dewi Lienggonegoro, Lisa Andriani Nikmah, Uly Alfi |
author_sort | Panjaitan, Novaria Sari Dewi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9707536 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-97075362022-11-30 Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Letter] Panjaitan, Novaria Sari Dewi Lienggonegoro, Lisa Andriani Nikmah, Uly Alfi Onco Targets Ther Letter Dove 2022-11-25 /pmc/articles/PMC9707536/ /pubmed/36457761 http://dx.doi.org/10.2147/OTT.S396547 Text en © 2022 Panjaitan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Letter Panjaitan, Novaria Sari Dewi Lienggonegoro, Lisa Andriani Nikmah, Uly Alfi Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Letter] |
title | Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Letter] |
title_full | Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Letter] |
title_fullStr | Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Letter] |
title_full_unstemmed | Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Letter] |
title_short | Response to Article “Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages” [Letter] |
title_sort | response to article “serum levels of galectin-9 are increased in cervical cancer patients and are higher in advanced clinical stages” [letter] |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707536/ https://www.ncbi.nlm.nih.gov/pubmed/36457761 http://dx.doi.org/10.2147/OTT.S396547 |
work_keys_str_mv | AT panjaitannovariasaridewi responsetoarticleserumlevelsofgalectin9areincreasedincervicalcancerpatientsandarehigherinadvancedclinicalstagesletter AT lienggonegorolisaandriani responsetoarticleserumlevelsofgalectin9areincreasedincervicalcancerpatientsandarehigherinadvancedclinicalstagesletter AT nikmahulyalfi responsetoarticleserumlevelsofgalectin9areincreasedincervicalcancerpatientsandarehigherinadvancedclinicalstagesletter |